(a) An Eligible Entity that seeks to participate in the Surplus Medication Program shall submit an application to the Department, on a form to be prescribed by the Director. An Eligible Entity may not participate in the program until it has received written or electronic documentation from the Director confirming that the Department has received its application and has confirmed that it qualifies as a Participating Entity.
(b) A Participating Entity shall disclose to the Department on a quarterly basis the name and location of the source of all donated Medications it receives.
(c) A participating primary care clinic, as described in Section 150201 of the California Health and Safety Code, shall disclose to the Department the name of the licensed physician who will be accountable to the California State Board of Pharmacy for the clinic’s program operations pursuant to Division 116 of the California Health and Safety Code and this Article 43. This physician must be the professional director, as defined in subdivision (c) of Section 4182 of the California Business and Professions Code.
(d) A Participating Entity shall keep complete records of the acquisition and disposition of Medication donated to, and transferred, dispensed, or destroyed under, the Surplus Medication Program. These records shall be kept separate from the Participating Entity’s other acquisition and disposition records and shall conform to the Pharmacy Law (Chapter 9 (commencing with Section 4000) of Division 2 of the Business and Professions Code), including being readily retrievable.
(e) The Board of Supervisors, the County Health Officer, and the California State Board of Pharmacy may prohibit an Eligible Entity or Participating Entity from participating in the Surplus Medication Program if the entity does not comply with the provisions of the program, pursuant to Division 116 of the California Health and Safety Code and this Article 43. If any one of the Board of Supervisors, the County Health Officer, or the California State Board of Pharmacy prohibits an Eligible Entity or Participating Entity from participating in the Surplus Medication Program, it shall provide written notice to the prohibited entity within 15 days of making this determination, and shall ensure that this notice also is provided to the other two (of the Board of Supervisors, County Health Officer, and California State Board of Pharmacy) not making the determination.
(Added by Ord. 247-18, File No. 180804, App. 10/26/2018, Eff. 11/26/2018)